Search Results

• Program Information

  The Department of Surgical Education at Orlando Health is dedicated to graduate medical education, offering a five-year, ACGME accredited general surgery residency program as well as accredited fellowships in Surgical Critical Care and Colon and Rectal Surgery. 

• Preparing for Your First Virtual Visit

  We offer convenient virtual care visits. You can have an appointment with an Orlando Health doctor online using your computer, smartphone or tablet in the privacy and comfort of your home.

• Program Information

  Orlando Health is a 1,780 bed system consisting of 8 hospitals:

• Program Information

  The Department of Obstetrics and Gynecology offers a four-year accredited residency program designed to provide extensive experience leading to board certification. The OB/GYN residency program started in 1951 and has grown steadily over the years, in both the number of residents and faculty. We currently accept 7 residents every incoming class. Our residency program is a hybrid of academic and community programs. Like many community programs, we have a high volume of patients. These patients have two distinct groups of providers: Patients that are seen in resident clinics, high risk OB clinic, local health departments, no prenatal care/no physician provider, and transfers from outside facilities are all provided care by the residents/faculty. And, there is a large number of private practice physicians who bring their patients to our facility for both obstetrical care and gynecologic surgery.

• Stop The Bleed - Training Class For The Community

  No matter how rapid the arrival of professional emergency responders, bystanders will always be first on the scene. A person who is bleeding can die from blood loss within five minutes; therefore, it is important to quickly stop the blood loss.

• Orlando Health Announces Plans for Regional Neuroscience Institute

  Orlando Health has announced plans to build a state-of-the-art neurosciences institute that will serve patients throughout the southeastern United

• Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

  Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

• Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  A Phase II study of Naxitamab added to induction Therapy for Subjects with Newly Diagnosed High Risk Neuroblastoma

• Visit Orlando partners with Orlando Health to launch health and wellness support for travel and tourism industry

  Orlando, FL (August 23, 2022) – Visit Orlando, the Official Tourism Association® for Orlando, and Orlando Health, a private, not-for-profit healthcare organization that serves the southeastern United States, have joined forces to create a unique partnership. The new alliance designates Orlando Health as the Official Health and Wellness Partner of Visit Orlando and offers health-related benefits for the millions of visitors who help make Orlando the most visited destination in the United States and Theme Park Capital of the World.

• Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma